Advanced company searchLink opens in new window

GYLDEN PHARMA LIMITED

Company number 09955881

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
24 Oct 2024 MA Memorandum and Articles of Association
24 Oct 2024 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
16 Oct 2024 CERTNM Company name changed emergex vaccines holding LIMITED\certificate issued on 16/10/24
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2024-10-10
04 Oct 2024 SH01 Statement of capital following an allotment of shares on 3 October 2024
  • GBP 40.869678
05 Sep 2024 TM01 Termination of appointment of Michael Derek Vaughn Rake as a director on 3 September 2024
09 Aug 2024 CS01 Confirmation statement made on 7 August 2024 with updates
12 Jul 2024 CH01 Director's details changed for Mr Sergio Pagani on 12 July 2024
10 Apr 2024 SH01 Statement of capital following an allotment of shares on 28 March 2024
  • GBP 40.749678
15 Jan 2024 AP01 Appointment of Dr Poh Hui Chia as a director on 5 January 2024
15 Jan 2024 TM01 Termination of appointment of Xinhong Lim as a director on 5 January 2024
23 Nov 2023 SH01 Statement of capital following an allotment of shares on 20 November 2023
  • GBP 40.721384
13 Nov 2023 AP01 Appointment of Dr Ricardo De Godoi Mattos Ferreira as a director on 27 September 2023
16 Oct 2023 AA Group of companies' accounts made up to 31 March 2023
03 Oct 2023 SH01 Statement of capital following an allotment of shares on 27 September 2023
  • GBP 40.721314
13 Sep 2023 SH01 Statement of capital following an allotment of shares on 21 August 2023
  • GBP 40.721238
21 Aug 2023 RESOLUTIONS Resolutions
  • RES13 ‐ Director ratification/ share option plan/ 08/08/2023
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
21 Aug 2023 MA Memorandum and Articles of Association
16 Aug 2023 CS01 Confirmation statement made on 7 August 2023 with updates
10 Jan 2023 AP01 Appointment of Sir Michael Derek Vaughn Rake as a director on 8 December 2022
16 Nov 2022 CH01 Director's details changed for Mr Sergio Pagani on 16 November 2022
18 Oct 2022 CH01 Director's details changed for Mr David Clifford Jackson on 18 October 2022
24 Sep 2022 AA Group of companies' accounts made up to 31 March 2022
17 Aug 2022 AP01 Appointment of Mr Frank Tufaro as a director on 17 August 2022
17 Aug 2022 TM01 Termination of appointment of Anthony David Sedgwick as a director on 17 August 2022
17 Aug 2022 AP01 Appointment of Mr David Clifford Jackson as a director on 17 August 2022